Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Why Index Level Rises Indicators explains the reasons behind rising index levels and how to respond with prudent actions.
23,291 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Rivian is plotting a bold three-year arc that hinges on scale, software, and partnerships. This guide breaks down the...
A fresh wave of buying interest in XRP, Solana, and Shiba Inu hits the market as traders watch key resistance levels ...
The software sector has faced a tough stretch, dragging some quantum plays into the red. This guide dives into whethe...
Mortgage rates have shifted from stubborn highs to a window of lower financing costs. This article shows how investor...
U.S. stocks paused as energy costs rose and Middle East tensions persisted. Citi cautions that iran conflicts just ad...
Real Brokerage reports 2025 revenue approaching $2 billion, signaling the strength of a platform-first approach that ...
Oil-driven demand shifts could threaten McDonald’s traffic and same-store sales, even as its franchise-heavy model cu...
Strategy MSTR short interest is rising as bearish bets mount, challenging the narrative around the companys Bitcoin s...
Goldman Sachs raises price targets on three major tech names by roughly 10%, reflecting improved growth visibility as...
Mortgage rates climbed above 6.25% to 6.41% as geopolitical tensions spiked, but housing demand still positive persis...
Meta is weighing large-scale staff reductions to accelerate its AI strategy, a move analysts warn could spark a wider...